Jeil Pharmaceutical has recently opened a new technology research centre in Yongin, Gyeonggi Province. The new research...
Singapore — GB Sciences has completed the technology transfer for the manufacturing of time-released nanoparticles...
Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatm...
Pharma major Lupin announced the launch of its Memantine Hydrochloride Extended-Release Capsules, 7mg, 14mg, 21mg, 28mg ...
GSK has recently announced that the expanded indication for Fluarix Tetra (Quadrivalent Influenza Vaccine) has been appr...
Pharma major Lupin has announced the launch of its Clobetasol Propionate Lotion 0.05% having received an approval from t...
In a significant development for Indian patients requiring treatment for structural or congenital heart disease and defe...
Cardinal Health has announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharm...
Singapore - The positive one-year results of a Heart Failure Telehealth programme, piloted by Changi General Hospital (C...
Singapore - NPL, the UK's National Measurement Institute (NMI) and UCL (University College London) have engineered a bra...
Singapore - Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight com...
Singapore - A new international study has made an important discovery about the key role of macrophages, a type of immun...
Singapore - Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved the Sp...
Adapsyn Bioscience Inc., a biotechnology company focused on the discovery and development of novel medicines derived fro...
Sangamo Therapeutics, Inc. and Pfizer has announced a collaboration for the development of a potential gene therapy usin...
Michigan based veterinary pharmaceutical and diagnostic company, Zomedica Pharmaceuticals has announced that it has ente...
Array BioPharma has announced that it has entered into a clinical trial collaboration agreement with Pfizer to investiga...
Sanofi and Regeneron has announced positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous s...
